Month: July 2021

Fort Lauderdale, Florida , July 07, 2021 (GLOBE NEWSWIRE) — LMP Automotive Holdings, Inc. (NASDAQ: LMPX) (“LMP” or the “Company”), an e-commerce and facilities-based automotive retailer in the United States, today Announced the Appointment of Robert Bellaflores as Chief Financial Officer. Robert Bellaflores has served as Senior Corporate Controller of LMP since April 16, 2021. Mr. Bellaflores has over 30 years of accounting experience in both public and private industry beginning his career at Deloitte & Touche in New York prior to moving to Florida in 1991. Prior to joining the Company, he was with the Projects Division of Steven Douglas & Associates from 2006 to 2021 as a senior level executive working with clients in Publications Media, Communications, Real Estate, Retail and Manufacturing industries. Prior to 2006,...

Insights Demonstrate Company’s Ability to Match Dealers with Ready-to-Buy Car Shoppers TAMPA, Fla., July 07, 2021 (GLOBE NEWSWIRE) — AutoWeb, Inc. (Nasdaq: AUTO), a robust digital marketing platform providing solutions for automotive dealers, agencies and OEMs, today announced the results of a comprehensive analysis performed, using a combination of AutoWeb and Experian® data, and a pilot program that integrates digital retailing components into AutoWeb’s consumer experience. This work reinforces AutoWeb’s unique ability to match dealers with high value in-market car buyers. Internal Data Results Multiple analyses of AutoWeb’s internal data revealed positive insights about its audience segments, demonstrating they are both local and ready-to-buy. With close rates of particular importance to AutoWeb’s customers, an internal analysis...

DUBLIN, Ireland, July 07, 2021 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in adults with narcolepsy, announced today that Greg Divis, Chief Executive Officer of Avadel, will participate in a fireside chat on Wednesday, July 14 at 11:00 a.m. ET. A live webcast of this event, as well as an archived recording, will be available on Avadel’s Investor Relations website, www.investors.avadel.com, for 90 days following the conference. About Avadel Pharmaceuticals plcAvadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company primarily focused on the development and FDA approval of FT218, an investigational, once-nightly, extended-release formulation...

New panel offers extensive improvements for pathogen identification and drug resistance gene testingIncreases targeted pathogens from 7 to 10 (140% increase) Increases targeted drug resistance genes from 13 to 35 (270% increase)Two-hour test for 45 specifc targets covers 10 pathogens and resistance markers for 4 classes of antimicrobialsBEVERLY, Mass., July 07, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced the release of its second-generation MiQLab™ Bacterial and AMR (Antibiotic / Antimicrobial Resistance) Panel. LexaGene’s first Bacterial and AMR Test screened samples for seven different pathogens and 13 different antimicrobial resistance factors. This first panel...

SAN FRANCISCO and SUZHOU, China, July 07, 2021 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced that its board of directors has authorized a share repurchase program under which, Adagene may repurchase up to US$20 million of its ordinary shares in the form of American depositary shares, subject to the relevant rules under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Company’s insider trading policy. “I am pleased to announce this share repurchase program, which is a strong indication of the Board’s confidence in Adagene’s globally differentiated pipeline driven by our proprietary NEObody, SAFEbody and POWERbody...

BOCA RATON, Fla., July 07, 2021 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator, announced that Franklin Bioscience OH, LLC, (“FBS – OH”), a licensed medical marijuana processor to which Jushi provides operational and consulting services, has received authorization to commence operations at the Company’s newly constructed 8,000 sq. ft., state-of-the-art processing facility (the “Facility”) located in Columbus, Ohio. Additionally, Jushi and FBS – OH have applied for a change of ownership to state regulators for FBS – OH to become a subsidiary of the Company. The Company expects FBS – OH to begin processing raw materials to produce carefully crafted, high-quality, and state approved products to supply the Ohio medical market. The...

BEIJING, July 07, 2021 (GLOBE NEWSWIRE) — ZW Data Action Technologies, Inc. (Nasdaq: CNET) (“ZW Data” or the “Company”), an integrated online advertising, precision marketing, data analytics, and other value-added services company, today announced that it has signed a strategic cooperation agreement with VCan Fintech, a Hong Kong-based financial technology company for global payment solutions (“VCan”). ZW Data has steadily built its Internet business ecosystem in the last 18 years. It has accumulated marketing and transaction data for nearly 100 million users for precision digital marketing. VCan provides global financing and payment solutions for cross-border e-commerce merchants. The two companies will start in-depth cooperation in three major aspects of business, operation, and technology. In business...

20-Year Industry Leader Antonio Gesteira Joins as Senior Managing Director to Support Increasing Demand for Investigations Expertise in Brazil SÃO PAULO, Brazil, July 07, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the addition of Senior Managing Director Antonio Gesteira to the firm’s Technology segment in Brazil. Mr. Gesteira, a forensic technology and e-discovery expert with more than 20 years of industry experience, will join the São Paulo office to establish and grow the Technology segment across the region. Brazilian corporations and law firms are increasingly seeking local, specialized practitioners for assistance in the face of an increasingly active investigations and e-discovery landscape. Mr. Gesteira will focus on building the Technology segment’s e-discovery and digital forensics solutions...